bariatric surgery vs glp 1 Metabolic and versus glucagon-like peptide-1 receptor agonist therapy: A comparison of cardiovascular outcomes in patients with obesity GLP-1 Analogues as a Complementary

CVOT, cardiovascular outcomes trial

For a three-month course of treatment, the total cost ranges from $24 to $150

Pharma giants are pouring tens of billions into new plants and acquisitions (summarized in Table 1), while CDMOs rush to expand peptide synthesis capacity and expertise

Scarpellini E, Arts J, Karamanolis G, Laurenius A, Siquini W, Suzuki H, et al

Prevalence of Diagnosed Type 1 and Type 2 Diabetes Among US Adults in 2016 and 2017: Population Based Study

High-polyphenol EVOO is a nutritional tool that may support metabolic health through multiple mechanisms, including modest support of natural GLP-1 secretion